Nova Anchora
PrivateLast Round
Seed
Apr 29, 2025
Company Overview
Nova Anchora is a biotechnology company developing corrective protein therapies for dystrophic epidermolysis bullosa.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nova Anchora Comparables
Compare Nova Anchora with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phoenicis Therapeutics | 84% | |
| BridgeBio Pharma, Inc. | 82% | |
| Aegle Therapeutics Corp | 81% |
Nova Anchora Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 29, 2025 |
Nova Anchora Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Viking Global Investors | Seed |
| DEBRA Research gGmbH | Seed |
Nova Anchora Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nova Anchora's valuation, stock price, and market status.
Is Nova Anchora a public or private company?
Nova Anchora is a private company.
What is the current stock price of Nova Anchora?
Nova Anchora is a private company with no public stock price. No recent secondary market data is available.
How much is Nova Anchora worth (valuation)?
Valuation information for Nova Anchora is not publicly available.
Can I buy Nova Anchora stock?
Nova Anchora shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nova Anchora's last funding round?
Nova Anchora's most recent funding round was Seed on April 29, 2025.
Who are the main investors in Nova Anchora?
Key investors in Nova Anchora include Viking Global Investors, DEBRA Research gGmbH.
Will Nova Anchora IPO soon?
No public IPO plans have been announced for Nova Anchora.
How can I track Nova Anchora secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nova Anchora's secondary market activity and sign up for updates.